Global White Biotechnology Market Is Estimated To Witness High Growth Owing To Rising Demand for Sustainable Solutions & Government Initiatives towards Bio-based Products
The white biotechnology market is estimated to be valued at US$ 207.5 Bn in 2019 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
White biotechnology, also known as industrial biotechnology, is the application of biotechnology for the production of industrial products through the use of bio-based processes. It involves the use of microorganisms or enzymes to produce sustainable solutions such as biofuels, bio-based chemicals, bio-based materials, and bio-based polymers. The market for white biotechnology is driven by the increasing demand for sustainable alternatives to fossil-based products and the rising focus on reducing carbon emissions and environmental impact.
Market Dynamics:
The white biotechnology market is driven by two key factors. Firstly, the rising demand for sustainable solutions across various industries such as chemicals, energy, and agriculture is expected to fuel market growth. The use of bio-based products helps in reducing greenhouse gas emissions, minimizing waste generation, and decreasing reliance on non-renewable resources.
Secondly, government initiatives and regulations promoting the use of bio-based products are expected to drive market growth. Many countries have implemented policies and regulations that support the development and adoption of bio-based products, providing incentives for companies to invest in white biotechnology.
Overall, the white biotechnology market is poised for high growth due to the increasing focus on sustainability and government support for bio-based products.
SWOT Analysis:
Strength: The white biotechnology market is expected to witness high growth due to increasing environmental concerns and the need for sustainable solutions. White biotechnology offers a range of eco-friendly products and processes that can help reduce waste, conserve resources, and minimize environmental impact.
Weakness: One weakness in the market is the high cost associated with the development and implementation of white biotechnology solutions. The initial investment required for research, development, and infrastructure can be a barrier for small-scale players. Additionally, there may be regulatory challenges and resistance from traditional industries that hinder the adoption of white biotechnology.
Opportunity: There are several opportunities in the white biotechnology market. The growing demand for biofuels and renewable energy sources creates a significant opportunity for white biotechnology companies to develop and commercialize bio-based alternatives. Additionally, the increasing consumer demand for sustainable and eco-friendly products presents an opportunity for white biotechnology companies to innovate and meet market needs.
Threats: The white biotechnology market faces competition from traditional industries and technologies that may be more established and have lower implementation costs. Additionally, there may be regulatory hurdles and public perception concerns surrounding genetically modified organisms (GMOs) and biotechnology, which could pose a threat to the market's growth.
Key Takeaways:
The Global White Biotechnology Marketis expected to witness high growth, exhibiting a CAGR of 4.7% over the forecast period. This growth can be attributed to increasing environmental concerns and the need for sustainable solutions. The Asia Pacific region is expected to be the fastest-growing and dominating region in the white biotechnology market, driven by the expanding industrial sector and government initiatives to promote sustainable development.
Key players operating in the white biotechnology market include Archer Daniels Midland Company, BASF SE, Cargill, Inc., Corbion N.V., Koninklijke DSM N.V, DuPont, Lesaffre, Novozymes, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., iCAD, Inc., InVivo Corporation, McKesson Corporation, Merge Healthcare Incorporated (IBM), Philips Healthcare, Samsung Medison Co. Ltd., Siemens Healthcare, and Toshiba Medical Systems Corporation. These players are focused on research and development activities, partnerships, and acquisitions to expand their product portfolios and strengthen their market position.
Read More:
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian